Scientific Programme

.

3 NOVEMBER 2021 - WEDNESDAY
Hours (CET) Hall A Hall B
14:00 - 14:05 Opening by ISAD President:
Jair C. Soares, United States
 
14:05 - 14:45 Plenary Session 1
Neuroimaging in Bipolar Disorder: How does it help us?

Chair: Jair C. Soares, United States
Speaker: Stephen M Strakowski, United States
 
14:45 - 14:55 Break
14:55 - 15:35 Industry Session  
15:35 - 15:45 Break
15:45 - 17:15 Symposium 1
Cohort power: Unique clinical and neurobiological insights from longitudinal European cohorts on Affective Disorders

Chair: Brenda Penninx, The Netherlands
NESDA: Netherlands Study of Depression and Anxiety

Brenda Penninx, The Netherlands
MACS: Marburg-Munster Affective Disorder Cohort Study

Tilo Kircher, Germany
The Italian REMIND project,
Maria Nobile, Italy
Symposium 2
The Value of Experimental Expertise for Patients with Mental Disorders

Chair: Eric Ruhe, The Netherlands
Regaining Personal Leadership During A Depression

Peter Oostelbos, The Netherlandsy
An Exploration of The Conditions For Deploying Self-Management Strategies: A Qualitative Study of Experiental Knowledge in Depression
Dorien Smit, The Netherlands
Best Practice Example of An Empowering Collaboration Between A Patient Association And A Pharmaceutical Company
Rebecca Müller, Belgium
Reducing Stigma in The Workspace
Marylou Selo, United States
17:15 - 17:25 Break
17:25 - 18:05 Rapid Oral Presentations 1
Chair: Anthony Cleare, United Kingdom
Mental health and perceived impact during the COVID-19 pandemic: two longitudinal studies in Dutch cohorts of persons with and without depressive, anxiety, and obsessive-compulsive disorders

Almar Kok, The Netherlands
Chronic social stress-induced deficient reward interest co-occurs with changes in basal amygdala-nucleus accumbens pathway and nucleus accumbens dopamine release in mice

Christopher Pryce, Switzerland
Screening programs for common maternal mental health disorders among postpartum women: A mixed methods systematic review & meta-analysis

Ahmed Waqas, United Kingdom
Bipolar disorder and comorbid substance use disorder: therapeutical options
Rita Trindade André, Portugal
Prediction of treatment outcome in patients with treatment resistant depression receiving multimodal inpatient treatment
Rachael W Taylor, United Kingdom
Neuropsychological and brain hemodynamic characterization of response to methylphenidate in children with ADHD: an unsupervised machine learning approach
Silvia Grazioli, Italy
 
18:05 - 18:15 Break
18:15 - 19:45 Symposium 3
Psychiatric comorbidities in bipolar disorders: double penalty and trajectories

Chair: Trine Vik Lagerberg, Norway
Psychiatric Comorbidities in Bipolar Disorders: Prevalence and Chronology of Onset According to Sex, Bipolar Subtype and childhood maltreatment,
Bruno Etain, France
A Trajectory Analysis of the Evolution of Familial and Non-Familial Bipolar I Disorder, Jan Scott, United Kingdom
Substance misuse trajectories and risk of relapse in the early course of bipolar disorder, Trine Vik Lagerberg, Norway

Symposium 4
Cognitive Interventions for Affective Disorders: what can we do and how might it help?

Chair: Rebecca Strawbridge, United Kingdom
Cognitive impairment in bipolar disorder: Is it reversible and/or treatable?

Lakshmi Yatham, Canada
Resting state EEG activity predicts response to cognitive training in patients with psychosis

Bruno Biagianti, Italy
Combining cognitive remediation with long-term psychotherapy to enhance recovery in affective disorders
Katie Douglas, New Zealand
Cognitive remediation for bipolar disorder: exploring treatment moderators for cognitive outcomes and transfer mechanisms to functional outcomes
Dimosthenis Tsapekos, United Kingdom
4 NOVEMBER 2021 - THURSDAY
Hours (CET) Hall A Hall B
13:00 - 14:00 The Journal of Affective Disorders Editorial Board Meeting
(Invitation Only)
 
14:00 - 14:05 Opening by International Scientific Programme Committee Chair:
Allan Young, United Kingdom
 
14:05 - 14:45 Plenary Session 2
Towards more understanding of depression’s course & heterogeneity: Findings from NESDA

Chair: Eric Ruhe, The Netherlands
Speaker: Brenda Penninx, The Netherlands
 
14:45 - 14:55 Break
14:55 - 16:25 Symposium 5
Discontinuation of antidepressants revisited: In who, when and how?

Chair: Eric Ruhe, The Netherlands
Antidepressant discontinuation: who can discontinue at what time?

Christiaan H. Vinkers, The Netherlands
Antidepressant withdrawal syndrome and its management

Mark Horowitz, United Kingdom
A multidisciplinary task-force formulating guidance how to discontinue SSRIs and SNRIs
Eric Ruhe, The Netherlands
Computational modelling of effort and reward decisions to predict relapse after antidepressant discontinuation
Isabel M. Berwian, United States
Symposium 6
Digital mental health tools for treating anxiety and depression across the life span

Chair: Bruno Biagianti, Italy
WASABI, a closed-loop mobile app to reduce social anxiety and improve social skills in socially anxious adolescents,

Bruno Biagianti, Italy
Ecological Tracking of Variations in Mood and Inhibitory Control and their relation to Depression and Mental Resilience
Mor Nahum, Israel
Reappraisal training reduces rumination – Evidence from self and social emotion regulation training
Noga Cohen, Israel
Specific Forms of Cognitive Training Bolster Mood Regulation and Contribute to Significant Reductions in Clinical Symptoms
Tom Van Vleet, United States
16:25 - 16:35 Break
16:35 - 17:15 Industry Session  
17:15 - 17:25 Break
17:25 - 18:05 Rapid Oral Presentations 2
Chair: Sagar Parikh, United States
Marital satisfaction and family functioning in couples with a bipolar partner

Ionut Popa, Romania
A scoping review of the effects of COVID-19 on European healthcare for people with major depressive disorder

Rebecca Strawbridge, United Kingdom
Clustering Analysis of Depression-Anxiety Symptoms Reveal Differences in Acoustic and Linguistic Measures of Speech

Danielle Desouza, Canada
The role of blame-related action tendencies in major depression: a virtual reality study
Suqian Duan, United Kingdom
Longitudinal associations between depressive symptoms, anxiety symptoms, and performance across four cognitive domains in older adults
Mariia Bocharova, United Kingdom
Association between parental control and subclinical depressive symptoms in a sample of college freshmen: Roles of empathy and gender
Wenjing Fei, China
 
18:05 - 18:15 Break
18:15 - 19:45 Symposium 7
Risk factors and correlates of mood and psychotic disorders among youngsters at high familial risk

Chair: Kathleen Merikangas, United States
Risk factors for conversion from major depression to bipolar disorder in a prospective high risk cohort study

Martin Preisig, Switzerland
Cognitive heterogeneity in the offspring of patients with schizophrenia or bipolar disorder: a cluster analysis across family risk

Isabel Valli, Spain
The impact of the co-parent’s mood psychopathology on the risk of mood disorders in offspring of probands with mood disorders: a prospective study
Caroline L. Vandeleura, Switzerland
Clinical Phenotypes and Endophenotypes among Offspring of Parents with Mood Disorder Spectrum the NIMH Family Study
Kathleen Merikangas, United States
Symposium 8
Clinical presentation of illness and determinants of treatment outcome in bipolar disorder: In Memoriam Hagop S Akiskal, MD

Chair: Aysegul Ozerdem, United States
The use of Akiskal’s TEMPS-A in neurobiological and clinical studies

Janusz K. Rybakowski, Poland
Antidepressant Non-Response and Switch Risk in Bipolar Depression
Mark A. Frye, United States
The effects of trauma history and PTSD comorbidity on illness course among bipolar disorder patients
Jair C. Soares, United States
19:45 - 19:55 Grab Your Glass and Join the Closing Ceremony
19:55 - 20:10 Closing Ceremony - Let's Raise a Glass Together